New Universal Science and Technology Co., Ltd. (SHE:300472)
China · Delayed Price · Currency is CNY 7.67
-0.05 (-0.65%)
At close: Feb 13, 2026
SHE:300472 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | -79.29 | 127.56 | 125.89 | 563.56 | 682.32 | 440.81 |
Other Revenue | 3.18 | 3.18 | 2.86 | 3.8 | 2.09 | 1.94 |
| -76.11 | 130.74 | 128.74 | 567.36 | 684.41 | 442.76 | |
Revenue Growth (YoY) | - | 1.55% | -77.31% | -17.10% | 54.58% | -8.88% |
Cost of Revenue | -16.08 | 152.93 | 145.52 | 399.8 | 479.45 | 317.67 |
Gross Profit | -60.04 | -22.19 | -16.78 | 167.56 | 204.96 | 125.08 |
Selling, General & Admin | 53.46 | 72.75 | 85.78 | 83.09 | 91.06 | 76.71 |
Research & Development | 8.14 | 37 | 54.92 | 58.25 | 69.54 | 41.37 |
Other Operating Expenses | 3.16 | 0.59 | 1.17 | 3.03 | 2.4 | 1.71 |
Operating Expenses | 151.32 | 246.11 | 186.16 | 252.77 | 221.71 | 176.91 |
Operating Income | -211.36 | -268.3 | -202.94 | -85.21 | -16.74 | -51.82 |
Interest Expense | -26.67 | -23.75 | -14.83 | -8.76 | -13.34 | -10.85 |
Interest & Investment Income | - | 33.09 | 1.18 | 0.12 | 0.57 | 0.11 |
Currency Exchange Gain (Loss) | -0.09 | -0.09 | 0.56 | 0.8 | 1.76 | -1.18 |
Other Non Operating Income (Expenses) | -5 | 17.1 | -2.56 | -6.95 | -11.3 | -1.62 |
EBT Excluding Unusual Items | -243.13 | -241.95 | -218.59 | -100 | -39.04 | -65.36 |
Impairment of Goodwill | -1.12 | -1.12 | - | - | -259.58 | -324.78 |
Gain (Loss) on Sale of Investments | -4.73 | -4.73 | - | -8.61 | -0.34 | -2.55 |
Gain (Loss) on Sale of Assets | 2.15 | -0.49 | 6.04 | 1.45 | 0.01 | 0.13 |
Asset Writedown | -128.71 | -128.54 | -4.21 | -4.7 | -14.67 | -9.88 |
Other Unusual Items | -10.08 | -11.06 | 2.48 | 2.49 | 13.66 | 20.25 |
Pretax Income | -385.61 | -387.89 | -214.28 | -109.37 | -299.96 | -382.18 |
Income Tax Expense | 82.52 | 58.45 | 17.46 | -11.13 | -1.74 | 1.71 |
Earnings From Continuing Operations | -468.13 | -446.34 | -231.74 | -98.24 | -298.22 | -383.89 |
Minority Interest in Earnings | 3.12 | 4.81 | 15.33 | 22.47 | 22.31 | 13.38 |
Net Income | -465.01 | -441.53 | -216.41 | -75.77 | -275.91 | -370.51 |
Net Income to Common | -465.01 | -441.53 | -216.41 | -75.77 | -275.91 | -370.51 |
Shares Outstanding (Basic) | 272 | 276 | 274 | 271 | 251 | 204 |
Shares Outstanding (Diluted) | 272 | 276 | 274 | 271 | 251 | 204 |
Shares Change (YoY) | -1.79% | 0.74% | 1.23% | 7.89% | 23.21% | -3.89% |
EPS (Basic) | -1.71 | -1.60 | -0.79 | -0.28 | -1.10 | -1.82 |
EPS (Diluted) | -1.71 | -1.60 | -0.79 | -0.28 | -1.10 | -1.82 |
Free Cash Flow | -48.93 | -158 | -73.81 | -124.86 | -269.64 | -132.66 |
Free Cash Flow Per Share | -0.18 | -0.57 | -0.27 | -0.46 | -1.07 | -0.65 |
Gross Margin | - | -16.97% | -13.03% | 29.53% | 29.95% | 28.25% |
Operating Margin | - | -205.21% | -157.63% | -15.02% | -2.45% | -11.71% |
Profit Margin | - | -337.71% | -168.09% | -13.36% | -40.31% | -83.68% |
Free Cash Flow Margin | - | -120.85% | -57.33% | -22.01% | -39.40% | -29.96% |
EBITDA | -180.81 | -243.16 | -185.01 | -68.61 | 2.36 | -34.08 |
EBITDA Margin | - | -185.98% | -143.70% | -12.09% | 0.34% | -7.70% |
D&A For EBITDA | 30.55 | 25.14 | 17.93 | 16.6 | 19.1 | 17.74 |
EBIT | -211.36 | -268.3 | -202.94 | -85.21 | -16.74 | -51.82 |
EBIT Margin | - | -205.21% | -157.63% | -15.02% | -2.45% | -11.71% |
Revenue as Reported | - | 130.74 | 128.74 | 567.36 | 684.41 | 442.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.